14 results
8-K
EX-1.1
ORTX
Orchard Therapeutics plc
6 Oct 22
Entry into a Material Definitive Agreement
4:34pm
be necessary to continue its business.
(ee) Cybersecurity. (i)(x) Except as disclosed in the Registration Statement and the Prospectus
8-K
EX-10.1
93reuxw jpfp
9 Feb 21
Orchard Therapeutics Announces $150 Million Strategic Financing
7:10am
POSASR
EX-1.2
yi9cz
28 Feb 20
Automatic shelf registration (post-effective amendment)
12:00am
F-1
EX-1.1
lz1v74dc4p9nkgq22yfd
3 Jun 19
Registration statement (foreign)
4:33pm
F-1/A
EX-1.1
5yay02pw
23 Oct 18
Registration statement (foreign) (amended)
6:15am
- Prev
- 1
- Next